Navigation Links
Bert W. O'Malley, M.D., Recipient of the 2008 National Medal for Science, Joins Bionovo's Scientific Advisory Board
Date:2/17/2009

EMERYVILLE, Calif., Feb. 17 /PRNewswire-FirstCall/ -- Bionovo Inc. (Nasdaq: BNVI) announced today the appointment of Bert O'Malley, M.D., to the company's Scientific Advisory Board. Dr. O'Malley, the recipient of the National Medal for Science in 2008, has extensive experience in academic research as well as with pharmaceutical and biotech companies.

"We are very excited to have Dr. O'Malley on the scientific advisory board as we are advancing our novel hormonal drug candidates," said Isaac Cohen, O.M.D., Bionovo's Chairman and CEO. He added, "Dr. O'Malley, a member of the National Academy of Sciences, and the recipient of the 2008 National Medal for Science, is a pioneer in biomedical research. Dr. O'Malley's landmark discoveries revealed the mechanism of hormone action and the critical importance of a previously undiscovered superfamily of mediators, the nuclear receptor coregulators. No doubt these discoveries have transformed the future of health and our ability to select safer, more targeted therapies for many critical indications. We are looking forward to collaborating with him on current and future indications involving nuclear receptors."

Dr. O'Malley states, "I'm delightfully surprised and impressed by the selectivity, safety and clinical effects of Menerba, Bionovo's drug candidate for menopausal hot flashes. To date, it is perhaps the most impressive SERM I've encountered. The utilization of natural compounds with historical clinical utility, and the targeted mechanism of action seems to result in a safer drug with exciting clinical results. I believe this strategy is propitious and will provide new therapies for many indications that currently have unmet or poorly met medical needs. I hope our collaboration will further expand therapeutic choices for a number of significant diseases with unmet need
'/>"/>

SOURCE Bionovo Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Aerovance Appoints Babatunde A. Otulana, M.D., as Chief Medical Officer
2. AcelRx Pharmaceuticals Hires Roman Skowronski, M.D., Ph.D. as Vice President of Clinical Development
3. Jonathan Lewis, M.D., Ph.D. Steps Down From Delcath Systems Board of Directors
4. Cerimon Pharmaceuticals Appoints James S. Shannon, M.D., to Board of Directors
5. Ethan Weiss, M.D., Joins Bionovos Scientific Advisory Board
6. Senesco Appoints Harlan W. Waksal, M.D., to Board of Directors
7. Cato T. Laurencin, M.D., Ph.D. to Join Osteotech Board of Directors
8. Orexigen(R) Therapeutics Appoints Dennis Kim, M.D., as Senior Vice President, Head of Obesity and Metabolic Disorders
9. Trusted LASIK Surgeons Welcomes Leading LASIK Eye Surgery Expert, Inventor David Huang, M.D., Los Angeles, to Its Unique Lasik Directory Service
10. Arete Therapeutics Names James Sabry, M.D., Ph.D., President and Chief Executive Officer
11. Daniel B. Dubin, M.D., Joins NanoBio Corp.s Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email: